Weigong Biotech Launches Class III Lymphocyte Subset Detection Reagents (Flow Cytometry Method): A Comprehensive Automated Solution for Immune Monitoring

Flow CytometryIn the clinical field, it is mainly used for oncology, hematologic disorders, infections and autoimmune diseases, organ transplantation, stem cells, and cell therapy.Clinical Flow CytometerWidely used in clinical laboratories across various medical institutions, serving areas such as disease diagnosis, treatment efficacy monitoring, and health management. Primarily used forLeukemia Immunophenotyping, Lymphocyte Subset Analysis, and Infectious Disease Testingetc. Among them,Lymphocyte Subset Assayis an important indicator for assessing the status, function, and balance of immunity。

The "Expert Consensus on Special Items for Health Checkups in the Population During the Convalescent Phase of Novel Coronavirus Infection," newly issued in 2023, points out that within six months after recovery from COVID-19,Lymphocyte Subset Analysis, in cases where the total lymphocyte count changes, various lymphocyte subsets may exhibit "unchanged proportions but altered absolute counts," with only detectionRelative Countthen abnormalities cannot be detected.Absolute CountIt can more intuitively reflect the changes in abnormal counts under normal subgroup proportions for clinical purposes; it is recommended that, conditions permitting,Simultaneous DetectionReport the relative and absolute counts of lymphocyte subsets. Lymphocyte testing is widely used in health checkups, showing a distinct upward trend, which has reignited interest in the flow cytometry sector.

Weigong TechnologyIn addition to absolute counting tubes and detection reagents, we also offer automated equipment for the entire flow cytometry workflow. Such automation is particularly critical when handling large-volume health screening samples, encompassing both pre-processing instruments and flow cytometers. This approach not only enhances the accuracy and efficiency of testing but also reduces costs and simplifies operational procedures.

In February 2024, the flow cytometry-based CD3 FITC/CD16+56 PE/CD45 PerCP/CD19 APC Detection Kit, independently developed by Weigong Technology, successfully received approval.Class III Medical Device Registration Certificate, at this pointWeigong Technology holds registered reagents in three categories: four-color lymphocyte subset detection reagents, six-color lymphocyte subset detection reagents, and four-color T-lymphocyte subset detection reagents.。

On Tuesday, May 21, at 19:30, VCBeat Select New Product Review Session No. 61 invited Dong Lifang, General Manager of the Marketing Center at Weigong Technology, to present their independently developedReagent for Detection of Three Lymphocyte Subsets (Flow Cytometry)andComprehensive Solutions for Lymphocyte Subsetsof promotional sharing.

Weigong Technology provides customers with high-quality, high-titer monoclonal antibodies that deliver satisfactory detection results even at low working concentrations.

Weigong Technology offers a diverse portfolio of lymphocyte subset detection products, providing users with flexible testing solutions to enhance laboratory workflow efficiency.

When used in conjunction with Weigong flow cytometers and Weigong sample pre-processing systems, it enables full-process automation of sample pre-processing, detection, analysis, and reporting.

Specializing in the development and production of monoclonal antibody reagents for lymphocyte subsets, leveraging professional expertise in antibody screening, conjugation, and quality assessment to provide customers with a wide range of high-quality antibodies for lymphocyte subset analysis.

Closed-system puncture sampling for blood collection tubes to avoid biological contamination from uncapping

10 Reagent Positions

Enables autonomous dispensing of samples, reagents, and hemolytic agents for unattended operation.

Capable of processing 40 flow cytometry tubes at a time

Customize Sample Preparation Protocols

Automatically generate the test list upon completion of testing.

Sample Preparation for Non-Washable Items

From left to right: Reagent kit + consumables (absolute counting tubes), Flow cytometry sample preparation instrument/EasySampler

① Sample Information Identification

② Sample Preparation

Routine Sample Testing

① Data

② Figure

Fully Automated Analysis Results

Scan the QR code on the poster to add our assistant and reserve your spot for the live stream.

Dong Lifang, General Manager of the Marketing Center at Weigong Technology

Graduated from Tianjin Medical University with a major in Clinical Laboratory Medicine

Supervisor Medical Technologist (Intermediate)

Participated in the implementation of the National Ministry of Science and Technology’s 863 Program project titled “New Generation High-Performance Five-Part Differential Cell Analysis System”

Participated in the drafting of the National Metrological Technical Specification of the People's Republic of China “JJF 1665-2017 Calibration Specification for Flow Cytometers”

Five Individual Invention Patents for Medical Device R&D

With 8 years of experience in medical device R&D, participated in the development of China’s first high-end five-part differential hematology analyzer, China’s first hematology analysis automation line, China’s first integrated slide-making and staining system, and China’s first clinical-grade flow cytometer. With 9 years of experience in medical device marketing, previously served as Marketing Director, Product Line Director, Academic Director, and core member of the Corporate Strategy Department at a well-known domestic listed IVD company.

Shenzhen Weigong Technology Co., Ltd. (“Weigong”) is an innovative high-tech enterprise established under the National High-Level Talent Program, specializing in the research and development as well as industrialization of in vitro diagnostic medical devices and reagents. It comprises three wholly-owned subsidiaries: Shenzhen Weigong Biotechnology Co., Ltd., Beijing Weigong Medical Technology Co., Ltd., and Hunan Weigong Biotechnology Co., Ltd.

Adhering to the philosophy and mission of “High Technology, High Quality, Serving the Public,” Weigong focuses on the fields of flow cytometry and flow fluorescence immunoassay. It has taken the lead in breaking through the patent barriers of foreign monopolistic enterprises and developed magnetic multi-dimensional encoded microspheres with independent intellectual property rights. The company has launched products including flow cytometers, flow sample pre-processing instruments, flow fluorescence immunoanalyzers, monoclonal antibody reagents, sperm function reagents, and flow fluorescence immunoassay reagents.

Since its inception, Weigong has secured multiple rounds of investment from prominent institutional investors. The company has been recognized with numerous accolades, including being named to the Venture 50 “New Sprout” Top 300 in 2018; the Venture 50 “Industry Leaders” Top 300 in 2021 and 2022; and the Venture 50 Healthcare Top 50 in 2022. Additional honors include third place in the 2019 China Medical Device Innovation and Entrepreneurship Competition; second prize in the 2020 “Maker Beijing” Innovation and Entrepreneurship Competition; inclusion in the “Top 5 Most Investable Companies” at the 2020 China Association for Science and Technology Innovation and Entrepreneurship Investment Conference; second prize in the 2021 “Entrepreneurship Beijing” Innovation and Entrepreneurship Competition; and the Excellence Award in the Biotechnology Category of the 2021 Ministry of Science and Technology National Disruptive Technology Innovation Competition.

“VCBeat Select New Product Showcase” is a live-streaming program under “VCBeat Select” designed to support medical enterprises in launching innovative products. The program’s mission is to facilitate the milestone launch of every innovative medical product.

Scan the QR code below to contact the assistant and reserve a spot for the live broadcast.

(If already added, please proactively contact the assistant.)